ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

HEW Ruling Limits Distribution Of Chemicals From Repository To Contractors, Government

May 7, 1976

In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored

October 24, 1997

Barakat Named Deputy Physician-in-Chief Of Memorial Sloan-Kettering’s Regional Care Network

October 18, 2013

Breast Cancer Task Force Reorganized, Foiled By Snow

March 2, 1979